|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,462.00 GBX | -0.85% |
|
-0.68% | -2.38% |
| 06-12 | AstraZeneca says Truqap combination approved in US for prostate cancer | AN |
| 06-12 | AstraZeneca Says FDA Approves Truqap Combination for PTEN-Deficient Prostate Cancer | MT |
| Market Cap | 280B 242B 223B 209B 392B 26,653B 398B 2,645B 1,027B 12,965B 1,052B 1,029B 44,894B | P/E Ratio 2026 * |
22.8x | P/E Ratio 2027 * | 19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 300B 259B 239B 224B 419B 28,516B 426B 2,830B 1,099B 13,872B 1,125B 1,101B 48,033B | EV / Sales 2026 * |
4.74x | EV / Sales 2027 * | 4.36x |
| Free-Float |
96.63% | Yield 2026 * |
1.85% | Yield 2027 * | 1.95% |
Last Transcript: AstraZeneca PLC
| 1 day | -0.85% | ||
| 1 week | -0.68% | ||
| Current month | -2.46% | ||
| 1 month | -0.30% | ||
| 3 months | -7.06% | ||
| 6 months | -0.99% | ||
| Current year | -2.38% |
| 1 week | 11,364 |  | 13,878 |
| 1 month | 11,232 | | 14,120 |
| Current year | 11,232 | | 15,732 |
| 1 year | 10,103 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,029 | | 15,732 |
| 10 years | 3,680 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Pam Cheng
COO | Chief Operating Officer | 55 | 2015-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-19 | Sell | See Remarks | -11,893 | 0.0008% | ||
| 05-13 | Fiscal year | Chief Executive Officer | 18,359 | 0.0012% | ||
| 05-05 | Free | See Remarks | 1 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.85% | -0.68% | +23.44% | +14.94% | 281B | |
| -2.41% | +0.69% | +40.12% | +154.01% | 1,035B | |
| +1.07% | +5.57% | +55.14% | +50.53% | 574B | |
| +1.32% | +1.24% | +18.92% | +64.81% | 397B | |
| +0.77% | +0.77% | +21.19% | +15.95% | 324B | |
| +0.44% | +5.39% | +25.86% | +35.39% | 278B | |
| +1.66% | +1.20% | -44.41% | -47.37% | 193B | |
| +0.32% | +2.78% | +21.72% | +62.37% | 191B | |
| -0.22% | -2.78% | +14.90% | +60.77% | 156B | |
| +0.15% | +2.02% | +7.07% | -32.74% | 149B | |
| Average | +0.46% | +1.70% | +18.39% | +37.87% | 357.91B | |
| Weighted average by Cap. | +0.50% | +2.37% | +28.02% | +67.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.32B 54.75B 50.43B 47.23B 88.57B 6,022B 89.91B 598B 232B 2,929B 238B 233B 10,143B | 67.16B 58.06B 53.48B 50.09B 93.93B 6,387B 95.35B 634B 246B 3,107B 252B 247B 10,757B |
| Net income | 12.43B 10.75B 9.9B 9.27B 17.39B 1,182B 17.65B 117B 45.57B 575B 46.65B 45.65B 1,991B | 14.09B 12.18B 11.22B 10.51B 19.7B 1,340B 20B 133B 51.64B 652B 52.86B 51.73B 2,256B |
| Net Debt | 19.6B 16.94B 15.61B 14.62B 27.41B 1,864B 27.82B 185B 71.84B 907B 73.54B 71.97B 3,139B | 12.67B 10.95B 10.09B 9.45B 17.72B 1,205B 17.99B 120B 46.44B 586B 47.54B 46.53B 2,029B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 13,462.00 p | -0.85% | 2,094,693 |
| 26-06-11 | 13,578.00 p | +0.85% | 2,231,675 |
| 26-06-10 | 13,464.00 p | -1.23% | 1,762,153 |
| 26-06-09 | 13,632.00 p | -1.19% | 1,908,834 |
| 26-06-08 | 13,796.00 p | -0.45% | 1,741,438 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
